Alpha Tau Medical Ltd. (DRTSW) Stock Competitors & Peer Comparison
See (DRTSW) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Specialties Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| DRTSW | $3.51 | -6.65% | 1.1B | -5.43 | -$0.65 | N/A |
| ALC | $67.35 | -3.84% | 32.9B | 21.18 | $3.18 | +0.53% |
| PHG | $26.58 | -0.64% | 25.8B | 15.19 | $1.75 | +3.73% |
| STE | $211.75 | -1.27% | 20.6B | 20.82 | $10.17 | +1.19% |
| BRKRP | $444.74 | +2.47% | 9.2B | 888.49 | $0.51 | +0.33% |
| SI | $20.80 | -0.91% | 430.3M | -10.84 | -$1.91 | N/A |
| MOBI | $11.99 | -0.17% | 398.7M | -0.64 | -$18.78 | N/A |
| CV | $7.02 | +4.00% | 350.7M | -2.81 | -$2.50 | N/A |
| MASS | $7.35 | +4.55% | 301.5M | -12.25 | -$0.60 | N/A |
| EDAP | $4.76 | -0.52% | 178.2M | -5.80 | -$0.82 | N/A |
Stock Comparison
DRTSW vs ALC Comparison July 2026
DRTSW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRTSW stands at 1.1B. In comparison, ALC has a market cap of 32.9B. Regarding current trading prices, DRTSW is priced at $3.51, while ALC trades at $67.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRTSW currently has a P/E ratio of -5.43, whereas ALC's P/E ratio is 21.18. In terms of profitability, DRTSW's ROE is -0.73%, compared to ALC's ROE of +0.04%. Regarding short-term risk, DRTSW is more volatile compared to ALC. This indicates potentially higher risk in terms of short-term price fluctuations for DRTSW.Check ALC's competition here
DRTSW vs PHG Comparison July 2026
DRTSW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRTSW stands at 1.1B. In comparison, PHG has a market cap of 25.8B. Regarding current trading prices, DRTSW is priced at $3.51, while PHG trades at $26.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRTSW currently has a P/E ratio of -5.43, whereas PHG's P/E ratio is 15.19. In terms of profitability, DRTSW's ROE is -0.73%, compared to PHG's ROE of +0.09%. Regarding short-term risk, DRTSW is more volatile compared to PHG. This indicates potentially higher risk in terms of short-term price fluctuations for DRTSW.Check PHG's competition here
DRTSW vs STE Comparison July 2026
DRTSW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRTSW stands at 1.1B. In comparison, STE has a market cap of 20.6B. Regarding current trading prices, DRTSW is priced at $3.51, while STE trades at $211.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRTSW currently has a P/E ratio of -5.43, whereas STE's P/E ratio is 20.82. In terms of profitability, DRTSW's ROE is -0.73%, compared to STE's ROE of +0.11%. Regarding short-term risk, DRTSW is more volatile compared to STE. This indicates potentially higher risk in terms of short-term price fluctuations for DRTSW.Check STE's competition here
DRTSW vs BRKRP Comparison July 2026
DRTSW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRTSW stands at 1.1B. In comparison, BRKRP has a market cap of 9.2B. Regarding current trading prices, DRTSW is priced at $3.51, while BRKRP trades at $444.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRTSW currently has a P/E ratio of -5.43, whereas BRKRP's P/E ratio is 888.49. In terms of profitability, DRTSW's ROE is -0.73%, compared to BRKRP's ROE of -0.01%. Regarding short-term risk, DRTSW is more volatile compared to BRKRP. This indicates potentially higher risk in terms of short-term price fluctuations for DRTSW.Check BRKRP's competition here
DRTSW vs SI Comparison July 2026
DRTSW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRTSW stands at 1.1B. In comparison, SI has a market cap of 430.3M. Regarding current trading prices, DRTSW is priced at $3.51, while SI trades at $20.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRTSW currently has a P/E ratio of -5.43, whereas SI's P/E ratio is -10.84. In terms of profitability, DRTSW's ROE is -0.73%, compared to SI's ROE of -0.35%. Regarding short-term risk, DRTSW is more volatile compared to SI. This indicates potentially higher risk in terms of short-term price fluctuations for DRTSW.Check SI's competition here
DRTSW vs MOBI Comparison July 2026
DRTSW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRTSW stands at 1.1B. In comparison, MOBI has a market cap of 398.7M. Regarding current trading prices, DRTSW is priced at $3.51, while MOBI trades at $11.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRTSW currently has a P/E ratio of -5.43, whereas MOBI's P/E ratio is -0.64. In terms of profitability, DRTSW's ROE is -0.73%, compared to MOBI's ROE of +0.31%. Regarding short-term risk, DRTSW is more volatile compared to MOBI. This indicates potentially higher risk in terms of short-term price fluctuations for DRTSW.Check MOBI's competition here
DRTSW vs CV Comparison July 2026
DRTSW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRTSW stands at 1.1B. In comparison, CV has a market cap of 350.7M. Regarding current trading prices, DRTSW is priced at $3.51, while CV trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRTSW currently has a P/E ratio of -5.43, whereas CV's P/E ratio is -2.81. In terms of profitability, DRTSW's ROE is -0.73%, compared to CV's ROE of +1.27%. Regarding short-term risk, DRTSW is more volatile compared to CV. This indicates potentially higher risk in terms of short-term price fluctuations for DRTSW.Check CV's competition here
DRTSW vs MASS Comparison July 2026
DRTSW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRTSW stands at 1.1B. In comparison, MASS has a market cap of 301.5M. Regarding current trading prices, DRTSW is priced at $3.51, while MASS trades at $7.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRTSW currently has a P/E ratio of -5.43, whereas MASS's P/E ratio is -12.25. In terms of profitability, DRTSW's ROE is -0.73%, compared to MASS's ROE of -0.26%. Regarding short-term risk, DRTSW is more volatile compared to MASS. This indicates potentially higher risk in terms of short-term price fluctuations for DRTSW.Check MASS's competition here
DRTSW vs EDAP Comparison July 2026
DRTSW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRTSW stands at 1.1B. In comparison, EDAP has a market cap of 178.2M. Regarding current trading prices, DRTSW is priced at $3.51, while EDAP trades at $4.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRTSW currently has a P/E ratio of -5.43, whereas EDAP's P/E ratio is -5.80. In terms of profitability, DRTSW's ROE is -0.73%, compared to EDAP's ROE of -1.49%. Regarding short-term risk, DRTSW is more volatile compared to EDAP. This indicates potentially higher risk in terms of short-term price fluctuations for DRTSW.Check EDAP's competition here
DRTSW vs APYX Comparison July 2026
DRTSW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRTSW stands at 1.1B. In comparison, APYX has a market cap of 172.7M. Regarding current trading prices, DRTSW is priced at $3.51, while APYX trades at $4.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRTSW currently has a P/E ratio of -5.43, whereas APYX's P/E ratio is -18.73. In terms of profitability, DRTSW's ROE is -0.73%, compared to APYX's ROE of -0.91%. Regarding short-term risk, DRTSW is more volatile compared to APYX. This indicates potentially higher risk in terms of short-term price fluctuations for DRTSW.Check APYX's competition here
DRTSW vs HYPR Comparison July 2026
DRTSW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRTSW stands at 1.1B. In comparison, HYPR has a market cap of 83.5M. Regarding current trading prices, DRTSW is priced at $3.51, while HYPR trades at $0.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRTSW currently has a P/E ratio of -5.43, whereas HYPR's P/E ratio is -2.48. In terms of profitability, DRTSW's ROE is -0.73%, compared to HYPR's ROE of -1.01%. Regarding short-term risk, DRTSW is more volatile compared to HYPR. This indicates potentially higher risk in terms of short-term price fluctuations for DRTSW.Check HYPR's competition here
DRTSW vs NYXH Comparison July 2026
DRTSW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRTSW stands at 1.1B. In comparison, NYXH has a market cap of 61M. Regarding current trading prices, DRTSW is priced at $3.51, while NYXH trades at $1.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRTSW currently has a P/E ratio of -5.43, whereas NYXH's P/E ratio is -0.62. In terms of profitability, DRTSW's ROE is -0.73%, compared to NYXH's ROE of -1.64%. Regarding short-term risk, DRTSW is more volatile compared to NYXH. This indicates potentially higher risk in terms of short-term price fluctuations for DRTSW.Check NYXH's competition here
DRTSW vs MDAI Comparison July 2026
DRTSW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRTSW stands at 1.1B. In comparison, MDAI has a market cap of 53.5M. Regarding current trading prices, DRTSW is priced at $3.51, while MDAI trades at $1.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRTSW currently has a P/E ratio of -5.43, whereas MDAI's P/E ratio is -3.73. In terms of profitability, DRTSW's ROE is -0.73%, compared to MDAI's ROE of +1.79%. Regarding short-term risk, DRTSW is more volatile compared to MDAI. This indicates potentially higher risk in terms of short-term price fluctuations for DRTSW.Check MDAI's competition here
DRTSW vs VNRX Comparison July 2026
DRTSW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRTSW stands at 1.1B. In comparison, VNRX has a market cap of 9.2M. Regarding current trading prices, DRTSW is priced at $3.51, while VNRX trades at $1.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRTSW currently has a P/E ratio of -5.43, whereas VNRX's P/E ratio is -0.52. In terms of profitability, DRTSW's ROE is -0.73%, compared to VNRX's ROE of +0.74%. Regarding short-term risk, DRTSW is more volatile compared to VNRX. This indicates potentially higher risk in terms of short-term price fluctuations for DRTSW.Check VNRX's competition here
DRTSW vs WOK Comparison July 2026
DRTSW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRTSW stands at 1.1B. In comparison, WOK has a market cap of 4.5M. Regarding current trading prices, DRTSW is priced at $3.51, while WOK trades at $1.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRTSW currently has a P/E ratio of -5.43, whereas WOK's P/E ratio is N/A. In terms of profitability, DRTSW's ROE is -0.73%, compared to WOK's ROE of -0.07%. Regarding short-term risk, DRTSW is more volatile compared to WOK. This indicates potentially higher risk in terms of short-term price fluctuations for DRTSW.Check WOK's competition here
DRTSW vs BIAFW Comparison July 2026
DRTSW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRTSW stands at 1.1B. In comparison, BIAFW has a market cap of 3.5M. Regarding current trading prices, DRTSW is priced at $3.51, while BIAFW trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRTSW currently has a P/E ratio of -5.43, whereas BIAFW's P/E ratio is 0.38. In terms of profitability, DRTSW's ROE is -0.73%, compared to BIAFW's ROE of -3.59%. Regarding short-term risk, DRTSW is less volatile compared to BIAFW. This indicates potentially lower risk in terms of short-term price fluctuations for DRTSW.Check BIAFW's competition here
DRTSW vs QTEXW Comparison July 2026
DRTSW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRTSW stands at 1.1B. In comparison, QTEXW has a market cap of 3.5M. Regarding current trading prices, DRTSW is priced at $3.51, while QTEXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRTSW currently has a P/E ratio of -5.43, whereas QTEXW's P/E ratio is -0.05. In terms of profitability, DRTSW's ROE is -0.73%, compared to QTEXW's ROE of N/A. Regarding short-term risk, DRTSW is less volatile compared to QTEXW. This indicates potentially lower risk in terms of short-term price fluctuations for DRTSW.Check QTEXW's competition here
DRTSW vs ITOC Comparison July 2026
DRTSW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRTSW stands at 1.1B. In comparison, ITOC has a market cap of 2.6M. Regarding current trading prices, DRTSW is priced at $3.51, while ITOC trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRTSW currently has a P/E ratio of -5.43, whereas ITOC's P/E ratio is -0.90. In terms of profitability, DRTSW's ROE is -0.73%, compared to ITOC's ROE of -0.94%. Regarding short-term risk, DRTSW is less volatile compared to ITOC. This indicates potentially lower risk in terms of short-term price fluctuations for DRTSW.Check ITOC's competition here
DRTSW vs FEED Comparison July 2026
DRTSW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRTSW stands at 1.1B. In comparison, FEED has a market cap of 391.3K. Regarding current trading prices, DRTSW is priced at $3.51, while FEED trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRTSW currently has a P/E ratio of -5.43, whereas FEED's P/E ratio is -0.01. In terms of profitability, DRTSW's ROE is -0.73%, compared to FEED's ROE of -0.44%. Regarding short-term risk, DRTSW is more volatile compared to FEED. This indicates potentially higher risk in terms of short-term price fluctuations for DRTSW.Check FEED's competition here